TNFRSF12A and neoplasm: The presence of FcγR-positive leukocytes within the tumor would allow the antibody to bridge leukocytes and tumor targets through binding to FcγR and TweakR, respectively, thus simultaneously modulating the functions of both tumor target cells and leukocytes.